Multiple Myeloma CancerConnect
Overview of Multiple Myeloma
Understand the symptoms, diagnosis and management of Multiple Myeloma
Understanding Stem Cell Transplants for Multiple Myeloma
ASH update: ASCT treatment of multiple myeloma improves outcomes even in individuals older than 70.;
Treatment for Stage II - III Multiple Myeloma
Treatment of stage II-III myeloma may include chemotherapy, precision medicines, stem cell transplant & supportive care.
Multiple Myeloma Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Multiple Myeloma Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Multiple Myeloma Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Multiple Myeloma Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Advances in Genomic Testing-What you Need to Know
Genomic-Genetic Testing: What is FISH, PCR, ctDNA and Microarrays? How are they performed and what is their role in the management of cancer?
Treatment of Recurrent Multiple Myeloma
Advances in CAR T-cell therapy, bispecific antibodies, and antibody drug conjugates continue and prolong the survival of individuals with recurrent myeloma.
Understanding Maintenance Therapy for Multiple Myeloma
Understand the risks-benefits of Revlimid, Ninlaro & Velcade maintenance therapy for Multiple Myeloma; 2019 ASH update.
Supportive Care for Multiple Myeloma
Management of bone complications, anemia, infections and other complications of Multiple Myeloma
Blenrep (belantamab mafodotin) for Multiple Myeloma
Blenrep targets BCMA in myeloma; has concerns of ocular side effects and could be a new standard of care for Relapsed/Refractory Multiple Myeloma
Daratumumab Shows Promise in High-Risk Smoldering Multiple Myeloma
Progression to active multiple myeloma delayed with daratumumab monotherapy among high-risk patients with smoldering myeloma
FDA Approves Isatuximab Combination for First-Line Treatment for Newly Diagnosed Multiple Myeloma
Approval based on results from trial data showing a 40% reduction in the risk of disease progression or death compared to the standard three-drug combination
COVID-19 Vaccines and Cancer
Fall 2023 Update: Vaccination against COVID-19 protects cancer patients. Answers to frequently asked questions about vaccine side effect, booster vaccines, and cancer.
Side Effects of Treatment: "Chemo Brain"
Understand the signs and symptoms of "chemo brain" and what you can do to prevent and cope.
Side Effects of Treatment: Fever/Infection
Fever and Infection are common side effecst of cancer treatment; why does it happen? When should you call the doctor? How can you prevent it?
Blood Cancers and COVID-19 - What You Need to Know
COVID-19 puts individuals with leukemia, lymphoma, myeloma and MPN's at risk - learn how to optimize your care.
September Is National Multiple Myeloma Awareness Month
House Leader Steve Scalise diagnosed with multiple myeloma - connect with others and learn about myeloma and recent advances in its treatment.